Cargando…

Renal capsular invasion is a prognostic biomarker in localized clear cell renal cell carcinoma

Renal capsular invasion (RCI) and lymphovascular invasion (LVI) are potential prognostic factors of significance in renal cell carcinoma (RCC). We evaluated the independent prognostic implications of RCI and LVI in localized clear cell RCC based on a large multi-institutional cohort. 6, 849 patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ha, U-Syn, Lee, Kyu Won, Jung, Jin-hyung, Byun, Seok-Soo, Kwak, Cheol, Chung, Jinsoo, Hwang, Eu Chang, Kim, Yong-June, Kwon, Tae Gyun, Kang, Seok Ho, Hong, Sung-Hoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760639/ https://www.ncbi.nlm.nih.gov/pubmed/29317731 http://dx.doi.org/10.1038/s41598-017-18466-9

Ejemplares similares

Publisher Correction: Renal capsular invasion is a prognostic biomarker in localized clear cell renal cell carcinoma
por: Ha, U-Syn, et al.
Publicado: (2018)

Optimal management of renal cell carcinoma in octogenarians: Retrospective analysis using updated Korean Renal Cell Carcinoma (KORCC) database
por: Kim, Jung Kwon, et al.
Publicado: (2023)

Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Nonmetastatic Renal Cell Carcinoma: A Large, Multicenter Cohort Analysis
por: Byun, Seok-Soo, et al.
Publicado: (2016)

Machine learning based prediction for oncologic outcomes of renal cell carcinoma after surgery using Korean Renal Cell Carcinoma (KORCC) database
por: Kim, Jung Kwon, et al.
Publicado: (2023)

Machine learning-based prediction model for late recurrence after surgery in patients with renal cell carcinoma
por: Kim, Hyung Min, et al.
Publicado: (2022)

The establishment of KORCC (KOrean Renal Cell Carcinoma) database
por: Byun, Seok-Soo, et al.
Publicado: (2016)

Impact of Young Age at Diagnosis on Survival in Patients with Surgically Treated Renal Cell Carcinoma: a Multicenter Study
por: Kang, Ho Won, et al.
Publicado: (2016)

Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy
por: Lee, Hakmin, et al.
Publicado: (2017)

Partial versus Radical Nephrectomy for T1-T2 Renal Cell Carcinoma in Patients with Chronic Kidney Disease Stage III: a Multiinstitutional Analysis of Kidney Function and Survival Rate
por: Chung, Jae-Seung, et al.
Publicado: (2018)

Prognostic significance of pathologic nodal positivity in non-metastatic patients with renal cell carcinoma who underwent radical or partial nephrectomy
por: Kim, Sung Han, et al.
Publicado: (2021)

Impact of preoperative thrombocytosis on prognosis after surgical treatment in pathological T1 and T2 renal cell carcinoma: results of a multi-institutional comprehensive study
por: Ha, Yun-Sok, et al.
Publicado: (2017)

Trends in clinical, operative, and pathologic characteristics of surgically treated renal mass in a Korean center: A surgical series from 1988 through 2015
por: Kang, Ho Won, et al.
Publicado: (2019)

Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database
por: Park, Jae Young, et al.
Publicado: (2020)

A Retrospective, Multicenter, Long-Term Follow-Up Analysis of the Prognostic Characteristics of Recurring Non-Metastatic Renal Cell Carcinoma After Partial or Radical Nephrectomy
por: Kim, Sung Han, et al.
Publicado: (2021)

The prognostic role of preoperative serum albumin/globulin ratio in patients with non-metastatic renal cell carcinoma undergoing partial or radical nephrectomy
por: Chung, Jae-Wook, et al.
Publicado: (2020)

Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma
por: Kim, Sung Han, et al.
Publicado: (2019)

Prognostic factors for overall survival in patients with clear cell metastatic renal cell carcinoma: Model development and external validation with Memorial Sloan Kettering Cancer Center model and the international metastatic renal cell carcinoma database consortium model
por: Shin, Dongrul, et al.
Publicado: (2021)

The number of metabolic features as a significant prognostic factor in patients with metastatic renal cell carcinoma
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

Survival and clinical prognostic factors in metastatic non‐clear cell renal cell carcinoma treated with targeted therapy: A multi‐institutional, retrospective study using the Korean metastatic renal cell carcinoma registry
por: Kim, Jung Kwon, et al.
Publicado: (2019)

Application of the International Metastatic Renal Cell Carcinoma Database Consortium and Memorial Sloan Kettering Cancer Center Risk Models in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multi-Institutional Retrospective Study Using the Korean Metastatic Renal Cell Carcinoma Registry
por: Kim, Jung Kwon, et al.
Publicado: (2019)

The platelet-to-lymphocyte ratio as a significant prognostic factor to predict survival outcomes in patients with synchronous metastatic renal cell carcinoma
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

Efficacy of First-Line Targeted Therapy in Real-World Korean Patients with Metastatic Renal Cell Carcinoma: Focus on Sunitinib and Pazopanib
por: Kim, Myung Soo, et al.
Publicado: (2018)

Deep learning based prediction of prognosis in nonmetastatic clear cell renal cell carcinoma
por: Byun, Seok-Soo, et al.
Publicado: (2021)

Methylation Signature for Prediction of Progression Free Survival in Surgically Treated Clear Cell Renal Cell Carcinoma
por: Kang, Ho Won, et al.
Publicado: (2019)

Outcomes of pathologic stage T3a renal cell carcinoma up-staged from small renal tumor: emphasis on partial nephrectomy
por: Lee, Hakmin, et al.
Publicado: (2018)

Clear cell papillary renal cell carcinoma: A case report and review of the literature
por: Kim, Sung Han, et al.
Publicado: (2018)

Association between Perioperative Blood Transfusion and Oncologic Outcomes after Curative Surgery for Renal Cell Carcinoma
por: Park, Yong Hyun, et al.
Publicado: (2016)

Novel immunotherapy in metastatic renal cell carcinoma
por: Cho, Yang Hyun, et al.
Publicado: (2017)

Preoperative Plasma Fibrinogen Level as a Significant Prognostic Factor in Patients With Localized Renal Cell Carcinoma After Surgical Treatment
por: Lee, Hakmin, et al.
Publicado: (2016)

Efficacy and Safety of Sorafenib Therapy on Metastatic Renal Cell Carcinoma in Korean Patients: Results from a Retrospective Multicenter Study
por: Kim, Sung Han, et al.
Publicado: (2015)

Primary Tumor Characteristics Are Important Prognostic Factors for Sorafenib-Treated Patients with Metastatic Renal Cell Carcinoma: A Retrospective Multicenter Study
por: Kim, Sung Han, et al.
Publicado: (2017)

The influence of prior laparoscopic experience on learning laparoendoscopic single site surgery: a prospective comparative preliminary study using cystorraphy in a live porcine model
por: Ha, U-Syn, et al.
Publicado: (2017)

A Prospective Multicenter Trial of the Efficacy and Tolerability of Neoadjuvant Sunitinib for Inoperable Metastatic Renal Cell Carcinoma
por: Kim, Sung Han, et al.
Publicado: (2016)

Comparison of Laparoscopic and Open Partial Nephrectomies in T1a Renal Cell Carcinoma: A Korean Multicenter Experience
por: Park, Hongzoo, et al.
Publicado: (2010)

Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma
por: Lee, Jii Bum, et al.
Publicado: (2019)

Current Status of Renal Biopsy for Small Renal Masses
por: Ha, Seung Beom, et al.
Publicado: (2014)

Significance of Intratumoral Fibrosis in Clear Cell Renal Cell Carcinoma
por: Joung, Jae Won, et al.
Publicado: (2018)

Implication of PHF2 Expression in Clear Cell Renal Cell Carcinoma
por: Lee, Cheol, et al.
Publicado: (2017)

Patients’ self-management of adverse events and patient-reported outcomes in advanced renal cell carcinoma treated with targeted therapies: A prospective, longitudinal, observational study
por: Hong, Sung-Hoo, et al.
Publicado: (2022)

Implication of cystic fluid cytology of renal cell carcinoma on surgical practice
por: Hur, Kyung Jae, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t1itnddneo4kv441orvfq3qnio